AMG
75
-7
CFG
93
-2
AIV
41
-2
WM
56
3
LMT
62
2
FLR
42
-4
USB
64
-2
BK
74
-5
NWS
46
-2
CHRW
73
-4
PPL
62
5
CNX
52
-8
HRB
41
3
ADSK
58
-4
IP
31
-6
AAL
51
-2
FTI
82
-2
DUK
50
3
COF
65
-3
SRE
54
-5
AMG
75
-7
CFG
93
-2
AIV
41
-2
WM
56
3
LMT
62
2
FLR
42
-4
USB
64
-2
BK
74
-5
NWS
46
-2
CHRW
73
-4
PPL
62
5
CNX
52
-8
HRB
41
3
ADSK
58
-4
IP
31
-6
AAL
51
-2
FTI
82
-2
DUK
50
3
COF
65
-3
SRE
54
-5
Financhill
Back

Franklin US Core Dividend Tilt Index ETF Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison

Sell
49

UDIV
Franklin US Core Dividend Tilt Index ETF

Last Price:
$53.28
Seasonality Move:
4.35%
Buy
67

RYTM
Rhythm Pharmaceuticals, Inc.

Last Price:
$113.86
Seasonality Move:
-9.01%
Sell
49
Franklin US Core Dividend Tilt Index ETF (UDIV) is a Sell

Is Franklin US Core Dividend Tilt Index ETF a Buy, Sell or Hold?

  • The current Franklin US Core Dividend Tilt Index ETF [UDIV] share price is $53.28. The Score for UDIV is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • UDIV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
67
Rhythm Pharmaceuticals, Inc. (RYTM) is a Buy

Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $113.56. The Score for RYTM is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

UDIV Stock Price Chart

What is Franklin US Core Dividend Tilt Index ETF's stock price today?

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals, Inc.'s stock price today?

  • The Rhythm Pharmaceuticals, Inc. share price today is $113.56
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.

UDIV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.33 Buy
Relative Strength Index (14 RSI): 53.74 Buy
Chaikin Money Flow: 541 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.98 - 53.62) Buy
Bollinger Bands (100): (50.39 - 53.05) Buy

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.67 Buy
Relative Strength Index (14 RSI): 59.45 Buy
Chaikin Money Flow: -357754 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (98.81 - 108.61) Buy
Bollinger Bands (100): (93.91 - 107.83) Buy

UDIV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.57 Sell
20-day SMA: 52.77 Buy
50-day SMA: 52.7 Buy
200-day SMA: 48.44 Buy
8-day EMA: 53.47 Sell
20-day EMA: 53.11 Buy
50-day EMA: 52.58 Buy
200-day EMA: 49.51 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 107.1 Buy
20-day SMA: 105.06 Buy
50-day SMA: 105.14 Buy
200-day SMA: 81.74 Buy
8-day EMA: 108.55 Buy
20-day EMA: 106.16 Buy
50-day EMA: 103.93 Buy
200-day EMA: 86.65 Buy

Franklin US Core Dividend Tilt Index ETF Earnings Growth & UDIV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.56 per share.

Franklin US Core Dividend Tilt Index ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):